VisVires New Protein

Investor type Venture Capital
Founders Matthieu Vermersch

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 15
Average round size
info
The average size of a deal this fund participated in
$30M
Portfolio companies 8
Rounds per year 3.00
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.47
Key employees 6
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Food and Beverage
  • Nutrition
  • Health Care
  • Sustainability
Summary

In 2014 was created VisVires New Protein, which is appeared as VC. The main department of described VC is located in the Singapore. The venture was found in Asia in Singapore.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the VisVires New Protein, startups are often financed by Emertec Gestion, Demeter Partners, Wilco. The meaningful sponsors for the fund in investment in the same round are Emertec Gestion, Bpifrance, Talis Capital. In the next rounds fund is usually obtained by Bpifrance, Talis Capital, Idinvest Partners.

Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has no exact preference in a number of founders of portfolio startups. In case when startup counts 2 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Ireland. Among the various public portfolio startups of the fund, we may underline Ynsect, Nuritas, mittemitte We can highlight the next thriving fund investment areas, such as Health Care, Therapeutics.

The fund was created by Matthieu Vermersch.

Speaking about the real fund results, this VC is 47 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of VisVires New Protein:
Typical Co-investors
VisVires New Protein is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after VisVires New Protein:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Singapore
Funds with similar focus located in Singapore:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Angel Investor Forum Bristol, Connecticut, United States
AVentures Capital Kyiv, Ukraine, Київська міська громада
Barshop Ventures San Antonio, Texas, United States
CMF Venture Capital -
ConocoPhillips Technology Ventures Houston, Texas, United States
Galaxy Finance Holding Group -
Hongjiao Capital China, Ningbo, Zhejiang
Jiufu Touzi Beijing, Beijing, China
Kendryx Enterprises Breckenridge, Colorado, United States
Luma Launch California, Santa Monica, United States
Luxmi Ventures -
Morgan Stanley Private Equity Asia -
Riverwood Capital California, Menlo Park, United States
Taihecap (Formerly TH Capital) Beijing, Beijing, China
Tail Wind Fund England, London, United Kingdom
Tembusu ICT Fund -
Varsity Ventures California, Stanford, United States
Yesmail Oregon, Portland, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Nuritas

Artificial Intelligence
Bioinformatics
Biotechnology
Data Mining
$46M11 Nov 2021 Dublin, County Dublin, Ireland

Aleph Farms

Food and Beverage
Green Consumer Goods
GreenTech
Nutrition
$105M07 Jul 2021 Rishon Lezion, Center District, Israel

ViAqua Therapeutics

Biotechnology
Health Care
Medical
Therapeutics
$4M09 Jun 2021 Misgav Regional Council, North District, Israel

In Ovo

Biotechnology
Health Care
Sustainability
Veterinary
29 Mar 2021 Leiden, South Holland, Netherlands

SwissDeCode

Biotechnology
Food and Beverage
Public Safety
Sustainability
$4M25 Jan 2021 Vaud, Switzerland

mittemitte

Environmental Engineering
Hardware
Internet of Things
Water Purification
$4M20 Dec 2019 Berlin, Berlin, Germany

Aleph Farms

Food and Beverage
Green Consumer Goods
GreenTech
Nutrition
$12M19 May 2019 Rishon Lezion, Center District, Israel

Nutrition Innovation

Food and Beverage
Food Processing
$5M14 Mar 2019 Central

Ynsect

Agriculture
AgTech
Animal Feed
Biotechnology
Farming
Nutrition
$148M20 Feb 2019 Ile-de-France
News
Collectiv Food raises $16M Series A to connect food producers directly with kitchens

– Collectiv Food, a food supply chain startup, raised $16m in Series A funding.
– The round was led by VNV Global and joined by VisVires New Protein, Octopus Ventures, Norrsken VC and existing investors, including Partech, Colle Capital and Mustard Seed.
– The company operates by sourcing food directly from producers, disintermediating the wholesaler middleman, and delivering straight to professional kitchens.
– Customers include Big Mamma Group, The Hush Collection, Dirty Bones, Megan’s, Crussh, Butchie’s, Cocotte, Tossed and Fresh Fitness Food.

Aleph Farms Raises $105M in Series B Funding

– Aleph Farms from Rehovot, Israel develops a non-genetically engineered cells isolated from a living cow to grow beef steaks.
– The company raised $105m in Series B funding.
– The round was led by Growth Fund and DistruptAD, with participation from Skyviews life Science, Thai Union, BRF, CJ CheilJedang, VisVires New Protein, Strauss Group, Cargill, Peregrine Ventures, and CPT Capital.
– The new investment will be used to scale up manufacturing and grow operations internationally ahead of initial market launch in 2022.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent VisVires New Protein?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: